Honigman Miller Schwartz and Cohn LLP
Tricyclic prodrugs
Prodrugs (I) and (Ia) of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.
Glactone Pharma Development AB
C C A A C A A
C07K C07D A61P A61K C07K A61K A61K
inventional inventional inventional inventional inventional inventional inventional
Olov Martin
Sterner Johansson